Share this on WhatsApp When federal Judge Matthew Kacsmaryk suspended the Food and Drug Administration (FDA) approval of the drug mifepristone on April 7, he significantly jeopardized access to abortion. In addition to dealing an immediate blow to accessing an essential and time-sensitive health care service, this decision also upended a drug approval system that … Continue reading A Bad Medication Abortion Decision Threatens the Future Availability of Drugs in the U.S.